(Q73371194)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738054%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Ten years of antisense inhibition of brain G-protein-coupled receptor function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738054%20AND%20SRC:MED&resulttype=core&format=json

G protein-coupled receptor

3 November 2019

main subject

1 reference

Dirk Van Oekelen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738054%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Walter H. M L. Luyten

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738054

31 December 2023

Josée E. Leysen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738054

31 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12738054

31 December 2023

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738054%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://api.elsevier.com/content/article/PII:S016501730300153X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

https://api.elsevier.com/content/article/PII:S016501730300153X?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Brain research. Brain research reviews

31 December 2023

published in

42

2

123–42

May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12738054

31 December 2023

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738054%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738054%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

123-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738054%20AND%20SRC:MED&resulttype=core&format=json

Intracerebroventricular treatment with an antisense oligodeoxynucleotide to kappa-opioid receptors inhibited kappa-agonist-induced analgesia in rats

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

A decrease in angiotensin receptor binding in rat brain nuclei by antisense oligonucleotides to the angiotensin AT1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Adenosine A1 receptor antisense infused in striatum of rats: actions on alcohol-induced locomotor impairment, blood alcohol, and body temperature.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligonucleotides induce functional deletion of ligand gated ion channels in cultured neurons and brain explants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Design and application of antisense oligonucleotides in cell culture, in vivo, and as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Opioid peptide receptor studies. 1. Identification of a novel delta-opioid receptor binding site in rat brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxynucleotides against mu- or kappa-opioid receptors block agonist-induced body temperature changes in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense confirmation of mu- and kappa-opioid receptor mediation of morphine's effects on body temperature in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Neuropeptide Y-Y1 receptor antisense oligodeoxynucleotide increases the infarct volume after middle cerebral artery occlusion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligonucleotide-induced reduction in 5-hydroxytryptamine7 receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Cerebellar CB(1) receptor mediation of Delta(9)-THC-induced motor incoordination and its potentiation by ethanol and modulation by the cerebellar adenosinergic A(1) receptor in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

AT(1) antisense distinguishes receptors mediating angiotensin II actions in solitary tract nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Down-regulation of mGluR5 by antisense deoxynucleotides alters pharmacological responses to applications of ACPD in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Central administration of dopamine D3 receptor antisense to rat: effects on locomotion, dopamine release and [3H]spiperone binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Nucleoside phosphorothioates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Human neuropeptide Y Y1 receptor antisense oligodeoxynucleotide specifically inhibits neuropeptide Y-evoked vasoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

The uptake and distribution of phosphorothioate oligonucleotides into vascular smooth muscle cells in vitro and in rabbit arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Dopamine D5 receptors in nucleus accumbens contribute to the detection of cocaine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Expression of antinociception in response to a signal for shock is blocked after selective downregulation of mu-opioid receptors in the rostral ventromedial medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

GABA(A), D1, and D5, but not progestin receptor, antagonist and anti-sense oligonucleotide infusions to the ventral tegmental area of cycling rats and hamsters attenuate lordosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligonucleotide sequences targeting the muscarinic type 2 acetylcholine receptor enhance performance in the Morris water maze

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense 'knockdowns' of M1 receptors induces transient anterograde amnesia in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Ca2+/Mg(2+)-dependent nuclease: tissue distribution, relationship to inter-nucleosomal DNA fragmentation and inhibition by Zn2+.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Inhibition of carrageenan-induced spinal c-Fos activation by systemically administered c-fos antisense oligodeoxynucleotides may be facilitated by local opening of the blood-spinal cord barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Inhibition of hippocampal kindling by metabotropic glutamate receptor antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Interaction of oligodeoxynucleotides with mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Specific regulation of gene expression by antisense, sense and antigene nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Dopamine D-5 receptor modulates hippocampal acetylcholine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Infusion of CCK-A receptor mRNA antisense oligodeoxynucleotides inhibits lordosis behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

In vitro and in vivo approaches to the characterization of the alpha2-adrenoceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

mu- and delta-opioid receptor antisense oligodeoxynucleotides antagonize morphine-induced growth hormone secretion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Bolus intravenous injection of phosphorothioate oligonucleotides causes hypotension by acting as alpha(1)-adrenergic receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

CB1 receptor density and CB1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Blockade of morphine supersensitivity by an antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Selective attenuation of mu-opioid receptor-mediated effects in rat sensory neurons by intrathecal administration of antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Functional blockade of opioid analgesia by orphanin FQ/nociceptin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Phosphorothioate oligodeoxynucleotides: antisense or anti-protein?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense targeting in behavioural neuroendocrinology.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Involvement of the Sst1 somatostatin receptor subtype in the intrahypothalamic neuronal network regulating growth hormone secretion: an in vitro and in vivo antisense study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Effect of supraspinal antisense oligodeoxynucleotide treatment on delta-opioid receptor mRNA levels in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Uptake and efflux of intact antisense phosphorothioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Suppression of ischemia-induced fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Characterization of oligonucleotide transport into living cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

NPY-Y1 receptor antisense injected centrally in rats causes hyperthermia and feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense to NPY-Y1 demonstrates that Y1 receptors in the hypothalamus underlie NPY hypothermia and feeding in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Delivery of angiotensin II type 1 receptor antisense inhibits angiotensin action in neurons from hypertensive rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Reduced expression of alpha2C-adrenoceptors in rat striatum following antisense oligodeoxynucleotide infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Alpha2C-adrenoceptors mediate inhibition of forskolin-stimulated cAMP production in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Sequence context of antisense RelA/NF-kappa B phosphorothioates determines specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Intracisternal antisense oligodeoxynucleotides to the thyrotropin-releasing hormone receptor blocked vagal-dependent stimulation of gastric emptying induced by acute cold in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Central TRH receptor 1 antisense blocks cold-induced gastric emptying but not brain c-Fos induction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Infusion of antisense oligodeoxynucleotides to the oxytocin receptor in the ventromedial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor binding in the female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense vasopressin oligonucleotides: uptake, turnover, distribution, toxicity and behavioral effects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

D3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Use of antisense oligodeoxynucleotide to determine delta-opioid receptor involvement in [D-Ala2]deltorphin II-induced locomotor hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligonucleotides in the study of neuroendocrine systems

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Mmu and D2 receptor antisense oligonucleotides injected in nucleus accumbens suppress high alcohol intake in genetic drinking HEP rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Effects of antisense oligonucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Opioid peptide receptor studies. 9. Identification of a novel non-mu- non-delta-like opioid peptide binding site in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxynucleotides as specific tools for studying neuroendocrine and behavioral functions: some prospects and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Central alpha 2-adrenoceptors and blood pressure regulation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Modulation of substance P/neurokinin-1 receptor in human astrocytoma cells by antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Knockdown of AMPA receptor GluR2 expression causes delayed neurodegeneration and increases damage by sublethal ischemia in hippocampal CA1 and CA3 neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Exposure to an antisense oligonucleotide decreases corticotropin-releasing factor receptor binding in rat pituitary cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Modulation of learned helplessness by 5-hydroxytryptamine2A receptor antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Intrastriatal adenosine A1 receptor antisense oligodeoxynucleotide blocks ethanol-induced motor incoordination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Autoradiographic evidence that intrastriatal administration of adenosine A(1) receptor antisense oligodeoxynucleotide decreases adenosine A(1) receptors in the rat striatum and cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

In vivo effects of partial phosphorothioated AT1 receptor antisense oligonucleotides in spontaneously hypertensive and normotensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Intracerebroventricular administration of AT1 receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Intracerebroventricular administration of angiotensin type 1 (AT1) receptor antisense oligonucleotides attenuate thirst in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Limited inhibition of 5-HT1A receptor expression in the rat brain by antisense RNA and oligodesoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Ribonuclease H activity in developing rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Regulation of serotonin2A receptor expression by an antisense oligodeoxynucleotide.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Serotonin2A receptor modulation of D1 dopamine receptor-mediated grooming behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

The effect of mu-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Effects of antisense to the (alpha)2A-adrenoceptors administered into the region of the locus ceruleus on behaviors in plus-maze and sexual behavior tests in sham-operated and castrated male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense inhibition of 5-hydroxytryptamine2a receptor induces an antidepressant-like effect in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligonucleotide to c-fos induces ipsilateral rotational behaviour to d-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

The spread and uptake pattern of intracerebrally administered oligonucleotides in nerve and glial cell populations of the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Inhibition of proopiomelanocortin expression by an oligodeoxynucleotide complementary to beta-endorphin mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense Oligodeoxynucleotides to the Cloned δ Receptor DOR‐1: Uptake, Stability, and Regulation of Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Phosphorothioate antisense oligodeoxynucleotides: questions of specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Physicochemical properties of phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxynucleotide to delta opioid receptors blocks cocaine-induced place preference in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Pharmacokinetics of antisense analogues in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

In vivo imaging of oligonucleotides with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Dopamine D3 receptor antisense reduces neuropeptide mRNA levels in rat nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

The antisense strategy applied to the study of dopamine D3 receptor functions in rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Dopamine D3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxynucleotide to a delta-opioid receptor given intrathecally blocks i.c.v. administered beta-endorphin-induced antinociception in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Pretreatment with beta-endorphin facilitates the attenuation of delta-opioid receptor-mediated antinociception caused by delta-opioid receptor antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Functional study of rat 5‐HT2A receptors using antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Dopamine D(1A) receptor function in a rodent model of tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Effects of oligonucleotide antisense to dopamine D(1A) receptor messenger RNA in a rodent model of levodopa-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Role of RNase H in hybrid-arrested translation by antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxynucleotide to a delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon- or kappa-opioid receptor agonists in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense strategies in dopamine receptor pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Inhibition of oncogene expression using vector-generated RNA antisense

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Oligodeoxynucleotide stability in subcellular extracts and culture media

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Specificity of antisense oligonucleotides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Hippocampal administration of kappa-opioid receptor antisense exacerbates isolation-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Kappa-opioid receptor antisense oligonucleotide injected into rat hippocampus causes hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Brain-stimulation reward thresholds raised by an antisense oligonucleotide for the M5 muscarinic receptor infused near dopamine cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Time course of changes in mu-opioid receptor mRNA levels in the periaqueductal gray of rat brain by a single or repeated injections of antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Central distribution and function of 5-HT6 receptor subtype in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Reduction in muscarinic receptors by antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Uptake and distribution of fluorescein-labeled D2 dopamine receptor antisense oligodeoxynucleotide in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Antisense inhibition of beta(1)-adrenergic receptor mRNA in a single dose produces a profound and prolonged reduction in high blood pressure in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Intrastriatal administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptor-mediated behavior and D2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900153-X

7 January 2021

Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA

6

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides

31 December 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Pharmacokinetic properties of several novel oligonucleotide analogs in mice

31 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors

31 December 2023

61

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells

31 December 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats

31 December 2023

102

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

In vitro and in vivo pharmacologic activities of antisense oligonucleotides

31 December 2023

109

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation

31 December 2023

141

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides

31 December 2023

144

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors

31 December 2023

150

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate

31 December 2023

151

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine

31 December 2023

162

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4

31 December 2023

173

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine

31 December 2023

215

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00153-X

31 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738054%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference